Fielder Capital Group LLC Has $699,000 Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Fielder Capital Group LLC boosted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 2.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,176 shares of the biotechnology company’s stock after buying an additional 25 shares during the period. Fielder Capital Group LLC’s holdings in Axon Enterprise were worth $699,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Bouchey Financial Group Ltd purchased a new position in shares of Axon Enterprise in the fourth quarter worth approximately $222,000. Proficio Capital Partners LLC acquired a new position in Axon Enterprise in the 4th quarter worth approximately $78,414,000. Kovack Advisors Inc. grew its position in Axon Enterprise by 3.7% during the 4th quarter. Kovack Advisors Inc. now owns 8,794 shares of the biotechnology company’s stock worth $5,226,000 after purchasing an additional 313 shares in the last quarter. Mn Services Vermogensbeheer B.V. raised its stake in Axon Enterprise by 4.0% during the 4th quarter. Mn Services Vermogensbeheer B.V. now owns 28,400 shares of the biotechnology company’s stock valued at $16,879,000 after purchasing an additional 1,100 shares during the period. Finally, New York Life Investment Management LLC lifted its holdings in shares of Axon Enterprise by 1.2% in the fourth quarter. New York Life Investment Management LLC now owns 9,721 shares of the biotechnology company’s stock valued at $5,777,000 after purchasing an additional 115 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the sale, the director now directly owns 24,259 shares in the company, valued at approximately $15,518,239.71. This represents a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 8,711 shares of company stock worth $5,631,561. 5.70% of the stock is owned by corporate insiders.

Axon Enterprise Trading Down 8.2 %

Axon Enterprise stock opened at $525.63 on Friday. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99. The company’s fifty day moving average price is $611.62 and its two-hundred day moving average price is $522.09. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market capitalization of $40.08 billion, a price-to-earnings ratio of 135.82, a PEG ratio of 5.17 and a beta of 1.05.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Barclays set a $726.00 price target on Axon Enterprise and gave the company an “overweight” rating in a report on Thursday. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price objective on the stock. in a research note on Thursday, February 20th. Finally, Robert W. Baird lifted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $587.38.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.